SCHEMBL485220

SCHEMBL485220

CC(C)(C)OC(=O)N1CCC2(CCN(c3ccc(C(F)(F)F)cc3)CC2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.53
GPR119 Q8TDV5 5/20 0.49
MAPT P10636 2/20 0.48
CYP3A4 P08684 3/20 0.47
TSHR P16473 2/20 0.47
HIF1A Q16665 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
RORC P51449 4/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HDAC2 Q92769 1/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
SCD5 Q86SK9 1/20 0.44
MGLL Q99685 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131400 0.93 GPR119 (0.54) GPR119MAPTCYP3A4TSHRHIF1A
SCHEMBL485607 0.88 HDAC2 (0.58) CYP11B2GPR119MAPTCYP3A4TSHR
SCHEMBL484886 0.85 CYP11B2 (0.55) CYP11B2GPR119MAPTCYP3A4TSHR
SCHEMBL30769248 0.85 CYP11B2 (0.55) CYP11B2GPR119MAPTCYP3A4TSHR
SCHEMBL484102 0.85 HIF1A (0.63) CYP11B2CYP3A4TSHRHIF1ACYP1A2
SCHEMBL485392 0.84 CYP11B2 (0.54) CYP11B2GPR119MAPTCYP3A4TSHR
SCHEMBL1459696 0.83 MAPT (0.64) GPR119MAPTTSHRALDH1A1LMNA
SCHEMBL484627 0.82 CYP11B2 (0.53) CYP11B2GPR119MAPTCYP3A4CYP2D6
SCHEMBL484535 0.82 CYP3A4 (0.55) CYP3A4TSHRHIF1ACYP1A2CYP2D6
SCHEMBL20503451 0.82 CYP11B2 (0.50) CYP11B2GPR119MAPTRORCHDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP11B2 2150/4885GPR119 206/4885MAPT 4634/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP11B2 2150/4885GPR119 206/4885MAPT 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.